Filing Flows › Lunai Bioworks (LNAI) › Q4 FY26
Lunai Bioworks (LNAI) Q4 FY26 earnings results (fourth quarter fiscal 2026)
10-K filed Oct 13, 2026
Lunai Bioworks (LNAI) reported revenue of $31K for the fourth quarter fiscal 2026 (Q4 FY26) and +48% from the quarter before.
Lunai Bioworks, Q4 FY26: revenue $31K, net loss $2.0M, operating cash flow −$1.8M. The chart follows the revenue to costs, profit and cash.
| Q4 FY26 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $31K | +48% | — |
| Operating profit | −$2.1M | — | — |
| Net earnings | −$2.0M | — | — |
| Operating cash flow | −$1.8M | — | — |
What changed
Revenue was $31K in Q4 FY26, up 48% from the previous quarter.
Operating costs exceeded revenue by $2.1M, an operating margin of -6888.6%. The quarter ended with a net loss of $2.0M, narrower than the previous quarter's $2.6M loss.
Operating cash flow was −$1.8M. Non-cash charges added back $30K of depreciation and amortization and $151K of share-based compensation.
Questions
What was Lunai Bioworks' revenue in the fourth quarter fiscal 2026?
Lunai Bioworks (LNAI) reported revenue of $31K for the fourth quarter fiscal 2026 (Q4 FY26) and +48% from the quarter before.
Source: Lunai Bioworks 10-K on SEC EDGAR.